Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of paricalcitol, a form of
synthetic vitamin D, in lowering parathyroid hormone (PTH) levels and reducing disease
symptoms in children and adults with X-linked hypophosphatemic (XLH) rickets.
Phase:
Phase 3
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)